A conserved family of immune effectors cleaves cellular ATP upon viral infection

Cell. 2023 Aug 17;186(17):3619-3631.e13. doi: 10.1016/j.cell.2023.07.020.

Abstract

During viral infection, cells can deploy immune strategies that deprive viruses of molecules essential for their replication. Here, we report a family of immune effectors in bacteria that, upon phage infection, degrade cellular adenosine triphosphate (ATP) and deoxyadenosine triphosphate (dATP) by cleaving the N-glycosidic bond between the adenine and sugar moieties. These ATP nucleosidase effectors are widely distributed within multiple bacterial defense systems, including cyclic oligonucleotide-based antiviral signaling systems (CBASS), prokaryotic argonautes, and nucleotide-binding leucine-rich repeat (NLR)-like proteins, and we show that ATP and dATP degradation during infection halts phage propagation. By analyzing homologs of the immune ATP nucleosidase domain, we discover and characterize Detocs, a family of bacterial defense systems with a two-component phosphotransfer-signaling architecture. The immune ATP nucleosidase domain is also encoded within diverse eukaryotic proteins with immune-like architectures, and we show biochemically that eukaryotic homologs preserve the ATP nucleosidase activity. Our findings suggest that ATP and dATP degradation is a cell-autonomous innate immune strategy conserved across the tree of life.

Keywords: ATP; CBASS; anti-phage; bacterial defense systems; innate immunity; phage; two-component system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate
  • Eukaryotic Cells
  • Humans
  • N-Glycosyl Hydrolases
  • Prokaryotic Cells
  • Virus Diseases*

Substances

  • Adenosine Triphosphate
  • N-Glycosyl Hydrolases